| P2093 | author name string | Scott E Lukas | |
| | Staci A Gruber | |
| | Kelly A Sagar | |
| | Atilla Gonenc | |
| | Ashley M Lambros | |
| | Korine B Cabrera | |
| | Mary K Dahlgren | |
| | Rosemary T Smith | |
| P2860 | cites work | Altered frontal cortical volume and decision making in adolescent cannabis users | Q21558374 |
| | Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings | Q21559698 |
| | Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology | Q24602238 |
| | An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions | Q24627250 |
| | The Role of Cannabinoids in Neuroanatomic Alterations in Cannabis Users | Q26768135 |
| | Brain development during childhood and adolescence: a longitudinal MRI study | Q28144698 |
| | An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets | Q29614928 |
| | The complex interaction between anxiety and cognition: insight from spatial and verbal working memory | Q30455991 |
| | Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study | Q30467197 |
| | Effects of cannabis on the adolescent brain | Q30653619 |
| | Dare to delay? The impacts of adolescent alcohol and marijuana use onset on cognition, brain structure, and function | Q30654825 |
| | Effect of a single dose of citalopram on amygdala response to emotional faces. | Q33575164 |
| | Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition | Q33700887 |
| | The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial. | Q50554671 |
| | Reflection impulsivity in adolescent cannabis users: a comparison with alcohol-using and non-substance-using adolescents. | Q51411117 |
| | Anterior cingulate cortex activation during cognitive interference in schizophrenia. | Q51942045 |
| | Neurocognitive consequences of marihuana--a comparison with pre-drug performance. | Q52056576 |
| | Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial. | Q52750107 |
| | Characterizing anterior cingulate activation in chronic schizophrenia: a group and single-subject fMRI study | Q57737019 |
| | Reliability of a Timeline Method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations | Q68447241 |
| | Endocannabinoid system dysfunction in mood and related disorders | Q37932017 |
| | Early onset marijuana use is associated with learning inefficiencies | Q38394718 |
| | Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review | Q38726957 |
| | Evidence for the Risks and Consequences of Adolescent Cannabis Exposure | Q38755199 |
| | Brain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects of Cannabis in Humans: Evidence from Studies of Adult Users. | Q38934198 |
| | Prevalence, reasons, perceived effects, and correlates of medical marijuana use: A review. | Q39155104 |
| | Cannabidiol in medical marijuana: Research vistas and potential opportunities. | Q39304449 |
| | Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users | Q39318898 |
| | Effect of baseline cannabis use and working-memory network function on changes in cannabis use in heavy cannabis users: a prospective fMRI study | Q39349906 |
| | Enhancing neuropsychological performance in chronic cannabis users: the role of motivation | Q39660541 |
| | A combined spectroscopic and functional MRI investigation of the dorsal anterior cingulate region in opiate addiction. | Q40249243 |
| | Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition | Q43970643 |
| | Possible evidence for re-regulation of HPA axis and brain reward systems over time in treatment in prescription opioid-dependent patients | Q44348570 |
| | Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing | Q45133109 |
| | Cannabis use and cognitive function: 8-year trajectory in a young adult cohort | Q46089484 |
| | Adolescent marijuana users have elevated risk-taking on the balloon analog risk task | Q46251445 |
| | The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study | Q46435454 |
| | Differential effects of chronic lithium and valproate on brain activation in healthy volunteers | Q46655610 |
| | A chronic low dose of Δ9-tetrahydrocannabinol (THC) restores cognitive function in old mice | Q48178199 |
| | The Multi-Source Interference Task: an fMRI task that reliably activates the cingulo-frontal-parietal cognitive/attention network | Q48218913 |
| | Specific attentional dysfunction in adults following early start of cannabis use. | Q48234562 |
| | Decreased Cingulate Cortex activation during cognitive control processing in bipolar disorder. | Q48307947 |
| | The Multi-Source Interference Task: validation study with fMRI in individual subjects | Q48399410 |
| | High-potency marijuana impairs executive function and inhibitory motor control | Q48935782 |
| | Neuroimaging of marijuana smokers during inhibitory processing: a pilot investigation | Q48952162 |
| | Cannabis dependence, cognitive control and attentional bias for cannabis words. | Q49056541 |
| | Escitalopram effects on insula and amygdala BOLD activation during emotional processing | Q33730062 |
| | Neurocognition in college-aged daily marijuana users | Q33820148 |
| | Abnormal cerebellar morphometry in abstinent adolescent marijuana users | Q33838292 |
| | Considering Cannabis: The Effects of Regular Cannabis Use on Neurocognition in Adolescents and Young Adults | Q33855815 |
| | Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected]. | Q34141036 |
| | Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids | Q34153898 |
| | Who are medical marijuana patients? Population characteristics from nine California assessment clinics | Q34209834 |
| | Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment | Q34304341 |
| | Hippocampal harms, protection and recovery following regular cannabis use | Q34508645 |
| | Effects of regular cannabis use on neurocognition, brain structure, and function: a systematic review of findings in adults | Q34556645 |
| | Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies | Q35053193 |
| | Cannabis and creativity: highly potent cannabis impairs divergent thinking in regular cannabis users | Q35108321 |
| | Cannabinoid modulation of functional connectivity within regions processing attentional salience | Q35420974 |
| | Psychological dysregulation, white matter disorganization and substance use disorders in adolescence | Q35613356 |
| | Age of onset of marijuana use and executive function | Q35936433 |
| | Effects of marijuana use on prefrontal and parietal volumes and cognition in emerging adults | Q35945157 |
| | Functional connectivity in brain networks underlying cognitive control in chronic cannabis users | Q36035942 |
| | The impact of initiation: Early onset marijuana smokers demonstrate altered Stroop performance and brain activation. | Q36132662 |
| | Neuropsychological performance in adolescent marijuana users with co-occurring alcohol use: A three-year longitudinal study | Q36249140 |
| | Cannabinoids and prefrontal cortical function: insights from preclinical studies | Q36436004 |
| | Functional MRI of inhibitory processing in abstinent adolescent marijuana users | Q36500693 |
| | Atomoxetine increases fronto-parietal functional MRI activation in attention-deficit/hyperactivity disorder: a pilot study | Q36570070 |
| | Impulsivity, attention, memory, and decision-making among adolescent marijuana users. | Q36636731 |
| | Marijuana Use Predicts Cognitive Performance on Tasks of Executive Function. | Q36717451 |
| | Age of onset of marijuana use impacts inhibitory processing. | Q36860579 |
| | An Analysis of Applicants Presenting to a Medical Marijuana Specialty Practice in California | Q36904018 |
| | Exaggerated activation of dorsal anterior cingulate cortex during cognitive interference: a monozygotic twin study of posttraumatic stress disorder | Q37171738 |
| | Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action | Q37285921 |
| | Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function | Q37336806 |
| | Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects | Q37341421 |
| | Association Between Lifetime Marijuana Use and Cognitive Function in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study | Q37413826 |
| | The chronic effects of cannabis on memory in humans: a review | Q37561234 |
| | Increased marijuana use and gender predict poorer cognitive functioning in adolescents and emerging adults. | Q37640798 |
| | The effect of pain on cognitive function: a review of clinical and preclinical research | Q37826944 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 983 | |
| P577 | publication date | 2017-01-01 | |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | The Grass Might Be Greener: Medical Marijuana Patients Exhibit Altered Brain Activity and Improved Executive Function after 3 Months of Treatment. | |
| P478 | volume | 8 | |